IGM Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
39.09
|
|
Average Rating
|
4.36
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.43
|
-1.32
|
0.11
|
7.69%
|
|
2022-06-30
|
-0.94
|
-1.33
|
-0.39
|
-41.49%
|
|
2022-03-31
|
-1.61
|
-1.53
|
0.08
|
4.97%
|
|
2021-12-31
|
-1.54
|
-1.50
|
0.04
|
2.60%
|
|
2021-09-30
|
-1.37
|
-1.32
|
0.05
|
3.65%
|
|
2021-06-30
|
-1.17
|
-1.16
|
0.01
|
0.85%
|
|
2021-03-31
|
-0.98
|
-0.95
|
0.03
|
3.06%
|
|
2020-12-31
|
-0.87
|
-0.79
|
0.08
|
9.20%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.18
|
|
2021-12-31
|
-4.93
|
|
2020-12-31
|
-2.65
|
|
2019-12-31
|
-5.59
|